Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126191
Status:
TERMINATED
Last Update Posted:
2013-05-23
First Post:
2005-08-02
Brief Title:
Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute